Position in ABBV
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,381,000
+$226,346 QoQ
Shares Held
5,488
+3.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#2,255
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Callahan Advisors, LLC holds $70,085,621 across 7 Drug Manufacturers - General names. ABBV ranks #5 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
106,466 | $27,039,170 | |
| 2 | LLY |
ELI LILLY & Co
|
21,791 | $26,136,781 | |
| 3 | PFE |
Pfizer Inc
|
471,052 | $11,342,932 | |
| 4 | MRK |
Merck & Co., Inc.
|
22,700 | $2,916,950 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
5,488 | $1,381,000 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
15,089 | $869,428 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,161 | $399,360 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,381,000 | 5,488 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,154,654 | 5,309 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,265,377 | 5,538 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,368,169 | 5,909 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $1,064,901 | 5,737 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $1,200,130 | 5,728 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $909,646 | 5,119 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $929,143 | 4,705 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $807,516 | 4,708 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $856,416 | 4,703 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $728,204 | 4,699 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $699,538 | 4,693 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $935,834 | 6,946 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $5,467,665 | 34,308 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $5,544,515 | 34,308 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $4,630,647 | 34,503 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,295,813 | 34,577 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $5,542,865 | 34,192 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $4,614,025 | 34,077 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $3,676,209 | 34,080 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $3,854,766 | 34,222 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $3,698,093 | 34,172 | Shares | Sole | 2021-04-21 | |
| 2020-12-31 | $3,650,814 | 34,072 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $2,990,410 | 34,141 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $3,253,783 | 33,141 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $1,698,046 | 22,287 | Shares | Sole | 2020-04-06 | |
| No filing history on record for this holder in this stock. | ||||||